Wednesday, November 14, 2012

The Election is Over, What Does this Mean for Drug Delivery Development in 2013?

Now that the 2012 election is over, it is important for you to know where drug delivery and device development will now fit into the 2013 pharmaceutical pipeline so you can prioritize your product development for the upcoming year.

Drug Delivery Partnerships 2013 is excited to bring you Billy Tauzin - Former U.S. Congressman, and former President and CEO of PhRMA, as well as a senior-level panel of policy and regulation heads at Pfizer, Johnson & Johnson, and Express Scripts.
Here are the Sessions this Year at DDP Focusing on the “Effects” of the 2012 Election:

The 2012 Election: Where Does this Leave the Pharmaceutical Industry?
A leading voice on healthcare as a member of Congress and a key player in the 2009 healthcare reform negotiations, Tauzin addresses the current state of healthcare reform and its implications for the pharmaceutical industry. His perspective from both the legislative side and the special interest side (as the former president and CEO of PhRMA) provides unique insights into one of today’s most debated issues. As a patient himself, recently battling a cancer diagnosis, he is one of only a handful of people who have experienced the many facets of the healthcare industry from all different perspectives. In this keynote presentation, he weaves his experiences as a patient and a policymaker together to address one of the most pressing issues today.

-Billy Tauzin, Former U.S. Congressman (Republican – Louisiana), Former President and CEO, PhRMA PANEL

How Has the Political Climate Affected Drug Development and Delivery and How is the Industry Coping?

By February, we’ll have re-elected or inaugurated a new President and we can only speculate how the election will affect the industry at this moment. In this panel session, senior executive policy leaders from many facets of the pharmaceutical and healthcare industry convene to discuss how the industry is moving forward through the regulatory system and how the current political landscape is affecting reimbursement.

Moderator: Sesha Neervannan, Vice President, Pharmaceutical Development, ALLERGAN


• Billy Tauzin, Former U.S. Congressman (R-LA), Former President and CEO, PhRMA

• Steven Miller, MD, Senior Vice President and CMO, EXPRESS SCRIPTS

• Steve Phillips, Senior Director, Health Policy & Reimbursement, JOHNSON & JOHNSON

• Brian Harvey, Vice President, US Regulatory, PFIZER

To find out more about these sessions and the rest of the program, download the agenda.

As a reader of the Drug Delivery blog, you get a 15% discount off the standard rate when using code XP1878BLOG. We look forward to seeing you February 6-8 in San Diego, CA! If you have any questions about the agenda or event, please contact Kate Devery at or visit our webpage.

The Drug Delivery Partnerships International Team

The DDP Homepage
DDP Twitter
The Drug Delivery Blog

No comments:

Post a Comment